Hims & Hers Health Q4 2023 GAAP EPS $0.01 Beats $(0.03) Estimate, Sales $246.62M Beat $245.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
Hims & Hers Health (HIMS) reported Q4 2023 earnings of $0.01 per share, surpassing the $(0.03) estimate, with sales of $246.62M exceeding the $245.82M forecast. This represents a 47.50% increase in sales compared to the same period last year.
February 26, 2024 | 9:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health (HIMS) exceeded Q4 2023 earnings and sales estimates, showing significant year-over-year growth.
Beating both earnings and sales estimates, especially with a significant year-over-year sales increase, typically leads to positive investor sentiment and could boost the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100